Top Markets
Coin of the day
Guangzhou Innogen Pharmaceutl Grp Co Ltd Guangzhou Innogen Pharmaceutl Grp Co Ltd

Guangzhou Innogen Pharmaceutl Grp Co Ltd

2591
Rank in Stocks #18331
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based... Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
Share Price
$0.45157959
Market Cap
$206.29M
Change (1 day)
-0.70%
Change (1 year)
-91.64%
Country
CN
Trade Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)

Category

P/S ratio for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591)
P/S ratio as of 2026 TTM: 0
According to Guangzhou Innogen Pharmaceutl Grp Co Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Guangzhou Innogen Pharmaceutl Grp Co Ltd from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.95 -
US
12.19 -
NL
24.99 -
US
3.75 -
AU
- -
CH